Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1722168PMC
http://dx.doi.org/10.1136/bjo.81.4.329dDOI Listing

Publication Analysis

Top Keywords

canalicular stenosis
4
stenosis course
4
course primary
4
primary herpes
4
herpes simplex
4
simplex infection
4
canalicular
1
course
1
primary
1
herpes
1

Similar Publications

Bicanalicular stent versus mono-canalicular stent for post-oncological lacrimal duct reconstruction: A retrospective cohort study.

J Plast Reconstr Aesthet Surg

November 2024

The Lacrimal Center, The Senior Department of Ophthalmology, The Third Medical Center of Chinese PLA General Hospital, 69 Yongding Road, Haidian District, Beijing 100039, China.

Article Synopsis
  • This study compares the outcomes of two different types of stents (bicanalicular and mono-canalicular) used for lacrimal duct reconstruction after cancer treatment, as previous comparisons were lacking.
  • A total of 75 patients were enrolled and divided into two groups, with significant differences found in stent duration and some postoperative complications like stent prolapse and punctal issues.
  • Overall, both stent types were equally effective in maintaining lacrimal duct function and minimizing tear overproduction post-surgery, highlighting the importance of appropriate case selection for optimal results.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to compare two surgical techniques for treating epiphora caused by punctal stenosis: canalicular triangular flap punctoplasty and triangular three-snip punctoplasty, using AS-OCT for assessment.
  • A total of 80 eyes from 43 patients were analyzed, with Group A (canalicular triangular flap) achieving a 100% anatomical success and 95% functional success, while Group B (triangular three-snip) achieved 75% anatomical and 77.5% functional success at 6 months.
  • The canalicular triangular flap technique was found to be more effective for both anatomical and functional outcomes compared to the three-snip method, highlighting the utility of AS-OCT for diagnosing and tracking punct
View Article and Find Full Text PDF

We report two cases of lacrimal obstruction after ocular infection with monkeypox virus (MPX) in the 2022 outbreak. One of them was a distal canalicular obstruction and the other was a proximal canalicular obstruction. In the first days of MPX they presented with conjunctivitis and periocular skin vesicles.

View Article and Find Full Text PDF

Radiation-Induced Acquired Lacrimal Drainage Obstructions: Management and Outcomes.

Semin Ophthalmol

January 2025

Ophthalmic Plastic Surgery Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA.

Article Synopsis
  • The study aimed to analyze how patients with radiation-induced acquired lacrimal duct obstructions (RALDO) were managed and their outcomes, using data from a single surgeon's retrospective chart review over five years.* -
  • Out of 16 patients with an average age of 63.3 years, most experienced epiphora symptoms about 9.5 months after radiation treatment related to various tumor types, with significant differences in the involvement of the right and left lacrimal drainage systems.* -
  • Surgical management of RALDO included various techniques based on the type and location of the obstruction, leading to tailored treatments like silicone tube placement and dilatation, with a variety of radiation therapies provided prior to the development of so
View Article and Find Full Text PDF

Background/aims: Data regarding the effectiveness of prophylactic systemic antibiotics (PSA) in lacrimal surgery is scarce. Therefore, we determined the postoperative surgical site infection (SSI) rate in lacrimal surgery without PSA.

Methods: We retrospectively analysed files of patients who underwent external (extDCR) or endoscopic endonasal dacryocystorhinostomy (endoDCR).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!